V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192991 | 20124122 | 1.66 | 89.45 | null | 2021-08-24 | 2021-09-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101775769 |
| 20192992 | 20124123 | 1.48 | 59.7 | Palliative (P) | 2019-07-18 | 2020-01-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100513061 |
| 20192994 | 20124124 | null | 67.3 | Adjuvant (A) | 2018-09-26 | 2018-09-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100963594 |
| 20192996 | 20124125 | 1.7 | 68 | Palliative (P) | 2019-09-16 | 2019-09-26 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100241698 |
| 20193001 | 20124126 | 1.66 | 37.4 | null | 2015-05-23 | 2016-04-19 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101374711 |
| 20193003 | 20124127 | 1.7 | 57.6 | Palliative (P) | 2016-05-22 | 2017-08-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100182182 |
| 20193008 | 20124128 | 1.76 | 104.8 | Adjuvant (A) | 2018-12-03 | 2018-12-19 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101290748 |
| 20193009 | 20124129 | null | 87.9 | Adjuvant (A) | 2019-07-24 | 2019-07-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100020233 |
| 20193010 | 20124130 | 1.88 | 72 | Disease modification (D) | 2015-10-29 | 2016-03-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101586268 |
| 20193012 | 20124131 | 1.54 | 69.5 | Palliative (P) | 2020-05-01 | 2020-05-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101255262 |
| 20193014 | 20124132 | 1.85 | 65.4 | Palliative (P) | 2020-12-15 | 2020-12-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101800064 |
| 20193016 | 20124133 | 1.67 | 65.7 | Palliative (P) | 2016-12-24 | 2016-12-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100028037 |
| 20193018 | 20124134 | 1.73 | 85 | null | 2016-11-28 | 2016-12-09 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101849602 |
| 20193020 | 20124135 | 1.61 | 84 | Palliative (P) | 2019-06-25 | 2019-07-17 | Docetaxel | 02 | N | DOCETAXEL | 100591948 |
| 20193024 | 20124136 | 1.87 | 54.5 | Palliative (P) | 2016-05-03 | 2016-05-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101758613 |
| 20193031 | 20124137 | 1.83 | 50.4 | null | 2018-11-14 | 2018-12-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 101238724 |
| 20193032 | 20124138 | 1.78 | 53 | Palliative (P) | 2018-10-15 | 2018-10-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101828808 |
| 20193033 | 20124139 | 1.6 | 88.8 | Palliative (P) | 2019-03-03 | 2019-09-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100367845 |
| 20193034 | 20124140 | 1.7 | 73 | Curative (C) | 2017-04-13 | 2017-04-27 | Docetaxel | 02 | N | DOCETAXEL | 100813181 |
| 20193035 | 20124141 | 1.81 | 48.5 | Palliative (P) | 2020-01-01 | 2020-01-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101697963 |
| 20193037 | 20124142 | null | 89.4 | Palliative (P) | 2016-03-26 | 2016-07-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101614408 |
| 20193038 | 20124143 | 1.76 | 108 | null | 2019-05-15 | 2019-06-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100363890 |
| 20193043 | 20124144 | 1.67 | 85.6 | Adjuvant (A) | 2018-04-14 | 2018-04-16 | Docetaxel | 02 | null | DOCETAXEL | 101075472 |
| 20193044 | 20124145 | 1.83 | 57 | null | 2018-08-28 | 2018-09-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101214985 |
| 20193050 | 20124146 | 0 | 68.9 | Adjuvant (A) | 2020-07-11 | 2020-07-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100653809 |
| 20193053 | 20124147 | 1.87 | 93.6 | Palliative (P) | 2018-10-09 | 2018-10-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100077449 |
| 20193054 | 20124148 | 1.7 | 66.3 | Palliative (P) | 2018-10-21 | 2018-10-31 | Docetaxel | 02 | N | DOCETAXEL | 100863743 |
| 20193055 | 20124149 | 1.86 | 90.6 | Adjuvant (A) | 2019-06-19 | 2019-06-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100772943 |
| 20193059 | 20124150 | 1.67 | 90.55 | null | 2017-09-16 | 2017-10-12 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100090198 |
| 20193065 | 20124151 | 1.7 | 88.9 | null | 2016-09-23 | 2016-09-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101378908 |
| 20193066 | 20124152 | 1.66 | 53.7 | Palliative (P) | 2020-02-27 | 2020-02-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101514750 |
| 20193067 | 20124153 | 1.74 | 52.4 | null | 2020-04-28 | 2020-05-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101303905 |
| 20193068 | 20124154 | 1.81 | 76 | null | 2019-08-24 | 2019-10-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101838561 |
| 20193070 | 20124155 | 1.61 | 71.8 | Palliative (P) | 2017-11-24 | 2017-11-26 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100299107 |
| 20193072 | 20124156 | 1.68 | 95 | Palliative (P) | 2018-03-06 | 2018-03-22 | Docetaxel | 02 | N | DOCETAXEL | 100156338 |
| 20193074 | 20124157 | 1.72 | 85 | Curative (C) | 2019-02-19 | 2019-02-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101843560 |
| 20193075 | 20124158 | 1.77 | 89 | Palliative (P) | 2020-01-30 | 2020-02-19 | CAPECITABINE + GEMCITABINE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101616892 |
| 20193078 | 20124159 | 1.63 | 52.9 | Palliative (P) | 2014-06-22 | 2016-04-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101362317 |
| 20193079 | 20124160 | 1.86 | 102 | Palliative (P) | 2016-12-21 | 2016-12-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101477267 |
| 20193080 | 20124161 | 1.7 | 93 | Palliative (P) | 2018-06-05 | 2018-06-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100206262 |
| 20193081 | 20124162 | 1.74 | 93.4 | Palliative (P) | 2017-03-14 | 2017-03-20 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100033225 |
| 20193082 | 20124163 | 1.67 | 66 | Adjuvant (A) | 2017-05-21 | 2017-06-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101435034 |
| 20193083 | 20124164 | 1.68 | 45.7 | Palliative (P) | 2017-12-03 | 2017-12-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100322906 |
| 20193087 | 20124165 | 1.59 | 56.4 | null | 2018-10-15 | 2018-10-16 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CAPECITABINE + GEMCITABINE | 101779401 |
| 20193091 | 20124166 | 1.54 | 96 | null | 2016-07-31 | 2016-08-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101629647 |
| 20193092 | 20124167 | 1.5 | 59 | Palliative (P) | 2017-08-19 | 2018-12-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101640974 |
| 20193104 | 20124168 | 1.69 | 55.5 | Palliative (P) | 2016-05-05 | 2016-06-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100328406 |
| 20193105 | 20124169 | 0 | 67.8 | Palliative (P) | 2018-05-17 | 2018-06-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100133604 |
| 20193106 | 20124170 | 1.59 | 101 | Palliative (P) | 2016-04-24 | 2016-05-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100223554 |
| 20193108 | 20124171 | 1.59 | 72.5 | Adjuvant (A) | 2019-08-19 | 2019-08-20 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100892743 |